CLINICAL_TRIALS
trial_result
· 2025-02-10
Clinical Trial Update: This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD) [NA]
Summary
This LMU project will evaluate whether an AI second-opinion report used to analyze retinal scans influences doctors' treatment decisions for neovascular Age-Rel…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johannes Schiefelbein | Conditions: Neovascular Age-Related Macular Degeneration (nAMD) | NA | Status: NOT_YET_RECRUITING